Clinical Trial: Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Gastroesophageal Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) - a Phase Ib Feasibility Trial
Brief Summary:
This is a phase 1b prospective, single arm, open-label trial determining the efficacy and feasibility of using a ctDNA assay (test) result to help guide neoadjuvant chemotherapy in subjects with Stage IB, II or Stage III adenocarcinoma of the stomach or gastroesophageal junction (GEA).
Read more